Defective dentate nucleus GABA receptors in essential tremor

Brain

Volumn 135, Issue 1, 2012, Pages 105-116

  Paris Robidas, Sarah ^a,b   Brochu, Elodie ^a,b   Sintes, Marion ^a,b   Emond, Vincent ^a,b   Bousquet, Mélanie ^a,b   Vandal, Milne ^a,b   Pilote, Mireille ^a,b   Tremblay, Cyntia ^a,b   Di Paolo, Thérse ^a,b   Rajput, Ali H ^c   Rajput, Alex ^c   Calon, Frédéric ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

cerebellum; deep cerebellar nuclei; dentate nucleus; essential tremor; GABA receptors

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; 4 AMINOBUTYRIC ACID B RECEPTOR; CYTOCHROME C OXIDASE; MESSENGER RNA;

AGE; AGED; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BRAIN LEVEL; CEREBELLUM CORTEX; CONTROLLED STUDY; DENTATE NUCLEUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ESSENTIAL TREMOR; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84856694665     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr301     Document Type: Article

References (107)

1. Adler CH, Shill HA, Beach TG. Essential tremor and Parkinson's disease: lack of a link. Mov Disord 2011; 26: 372-7.
2. Albin RL, Price RH, Sakurai SY, Penney JB, Young AB. Excitatory and inhibitory amino acid binding sites in human dentate nucleus. Brain Res 1991; 560: 350-3.
3. Atz M, Walsh D, Cartagena P, Li J, Evans S, Choudary P, et al. Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 2007; 163: 295-309. (Pubitemid 46874608)
4. Axelrad JE, Louis ED, Honig LS, Flores I, Ross GW, Pahwa R, et al. Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol 2008; 65: 101-7.
5. Benito-Leon J, Louis ED, Bermejo-Pareja F. Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry 2009; 80: 423-5.
6. Benke D, Honer M, Michel C, Bettler B, Mohler H. Gamma-aminobutyric acid type B receptor splice variant proteins GBR1a and GBR1b are both associated with GBR2 in situ and display differential regional and sub-cellular distribution. J Biol Chem 1999; 274: 27323-30.
7. Bettler B, Tiao JY. Molecular diversity, trafficking and subcellular localization of GABAB receptors. Pharmacol Ther 2006; 110: 533-43.
8. Billinton A, Ige AO, Wise A, White JH, Disney GH, Marshall FH, et al. GABA(B) receptor heterodimer-component localisation in human brain. Mol Brain Res 2000; 77: 111-24. (Pubitemid 30256197)
9. Billinton A, Upton N, Bowery NG. GABA(B) receptor isoforms GBR1a and GBR1b, appear to be associated with pre-and post-synaptic elements respectively in rat and human cerebellum. Br J Pharmacol 1999; 126: 1387-92. (Pubitemid 29142070)
10. Bischoff S, Leonhard S, Reymann N, Schuler V, Shigemoto R, Kaupmann K, et al. Spatial distribution of GABA(B)R1 receptor mRNA and binding sites in the rat brain. J Comp Neurol 1999; 412: 1-16. (Pubitemid 29380321)
11. Boecker H, Weindl A, Brooks DJ, Ceballos-Baumann AO, Liedtke C, Miederer M, et al. GABAergic dysfunction in essential tremor: an 11C-flumazenil PET study. J Nucl Med 2010; 51: 1030-5.
12. Bowery NG. Historical perspective and emergence of the GABAB receptor. Adv Pharmacol 2010; 58: 1-18.
13. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, et al. International union of pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev 2002; 54: 247-64. (Pubitemid 34575715)
14. Bowery NG, Hudson AL, Price GW. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 1987; 20: 365-83. (Pubitemid 17048701)
15. Brooks VB, Kozlovskaya IB, Atkin A, Horvath FE, Uno M. Effects of cooling dentate nucleus on tracking-task performance in monkeys. J Neurophysiol 1973; 36: 974-95.
16. Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, et al. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter. Synapse 2001; 40: 225-34. (Pubitemid 32322215)
17. Calon F, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bedard PJ, et al. Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzo-diazepine receptor complex and GABA content. Neurochem Int 1999; 35: 81-91. (Pubitemid 29251232)
18. Calon F, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bedard PJ, et al. 125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments. Exp Neurol 2000; 163: 191-9. (Pubitemid 30314374)
19. Calon F, Morissette M, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T. Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications. Mov Disord 2003a; 18: 241-53. (Pubitemid 36410820)
20. Calon F, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson disease. Neurobiol Dis 2003b; 14: 404-16. (Pubitemid 37543519)
21. Catts VS, Catts SV, Fernandez HR, Taylor JM, Coulson EJ, Lutze-Mann LH. A microarray study of post-mortem mRNA degradation in mouse brain tissue. Brain Res Mol Brain Res 2005; 138: 164-77. (Pubitemid 41138035)
22. Cavanagh JB, Holton JL, Nolan CC, Ray DE, Naik JT, Mantle PG. The effects of the tremorgenic mycotoxin penitrem A on the rat cerebellum. Vet Pathol 1998; 35: 53-63. (Pubitemid 28044793)
23. Chen K, Li HZ, Ye N, Zhang J, Wang JJ. Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpo-situs nucleus neurons in vitro. Brain Res Bull 2005; 67: 310-8. (Pubitemid 41354781)
24. Chu DC, Albin RL, Young AB, Penney JB. Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative auto-radiographic study. Neuroscience 1990; 34: 341-57. (Pubitemid 20110140)
25. Clark JA, Mezey E, Lam AS, Bonner TI. Distribution of the GABA(B) receptor subunit gb2 in rat CNS. Brain Res 2000; 860: 41-52. (Pubitemid 30155836)
26. Cooke JD, Thomas JS. Forearm oscillation during cooling of the dentate mucleus in the monkey. Can J Physiol Pharmacol 1976; 54: 430-6.
27. DeLong MR. Possible involvement of central pacemakers in clinical disorders of movement. Fed Proc 1978; 37: 2171-5.
28. Dennis T, Dubois A, Benavides J, Scatton B. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. J Pharmacol Exp Ther 1988; 247: 309-22.
29. Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurol 2011; 10: 148-61.
30. Deuschl G, Wenzelburger R, Loffler K, Raethjen J, Stolze H. Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Brain 2000; 123: 1568-80. (Pubitemid 30481181)
31. Durkin MM, Gunwaldsen CA, Borowsky B, Jones KA, Branchek TA. An in situ hybridization study of the distribution of the GABA(B2) protein mRNA in the rat CNS. Brain Res Mol Brain Res 1999; 71: 185-200. (Pubitemid 29492963)
32. Elble RJ, Deuschl G. An update on essential tremor. Curr Neurol Neurosci Rep 2009; 9: 273-7.
33. Ferrara JM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. J Neurol Sci 2009; 285: 195-7.
34. Gambarana C, Loria CJ, Siegel RE. GABAA receptor messenger RNA expression in the deep cerebellar nuclei of Purkinje cell degeneration mutants is maintained following the loss of innervating Purkinje neurons. Neuroscience 1993; 52: 63-71. (Pubitemid 23026607)
35. Goldberger ME, Growdon JH. Pattern of recovery following cerebellar deep nuclear lesions in monkeys. Exp Neurol 1973; 39: 307-22.
36. Growdon JH, Chambers WW, Liu CN. An experimental study of cere-bellar dyskinesia in the rhesus monkey. Brain 1967; 90: 603-32.
37. Heck D, Sultan F. Cerebellar structure and function: making sense of parallel fibers. Hum Mov Sci 2002; 21: 411-21.
38. Hevner RF, Wong-Riley MT. Neuronal expression of nuclear and mito-chondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J Neurosci 1991; 11: 1942-58.
39. Hirsch EC, Perier C, Orieux G, Francois C, Feger J, Yelnik J, et al. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci 2000; 23: S78-85.
40. Iles JF, Pearson KG. Central patterning of motoneuronal activity in the cockroach. J Physiol 1969; 204: 54P-55P.
41. Ilinsky IA, Kultas-Ilinsky K. Motor thalamic circuits in primates with emphasis on the area targeted in treatment of movement disorders. Mov Disord 2002; 17 (Suppl. 3): S9-14.
42. Ito M, Yoshida M, Obata K, Kawai N, Udo M. Inhibitory control of intracerebellar nuclei by the Purkinje cell axons. Exp Brain Res 1970; 10: 64-80.
43. Jahnsen H. Extracellular activation and membrane conductances of neurones in the guinea-pig deep cerebellar nuclei in vitro. J Physiol 1986; 372: 149-68. (Pubitemid 16048147)
44. Jain S, Lo SE, Louis ED. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol 2006; 63: 1100-4. (Pubitemid 44232315)
45. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998; 396: 674-9. (Pubitemid 29003945)
46. Julien C, Tremblay C, Bendjelloul F, Phivilay A, Coulombe MA, Emond V, et al. Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology. J Neurosci Res 2008; 86: 2292-302.
47. Julien C, Tremblay C, Emond V, Lebbadi M, Salem NJ, Bennett DA, Calon F. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 2009; 68: 48-58.
48. Kane A, Hutchison WD, Hodaie M, Lozano AM, Dostrovsky JO. Enhanced synchronization of thalamic theta band local field potentials in patients with essential tremor. Exp Neurol 2009; 217: 171-6.
49. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol Brain Res 1995; 28: 311-8.
50. Kingsbury AE, Wilkin GP, Patel AJ, Balazs R. Distribution of GABA receptors in the rat cerebellum. J Neurochem 1980; 35: 739-42. (Pubitemid 10046907)
51. Kralic JE, Criswell HE, Osterman JL, O'Buckley TK, Wilkie ME, Matthews DB, et al. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest 2005; 115: 774-9. (Pubitemid 40322254)
52. Kulik A, Nakadate K, Nyiri G, Notomi T, Malitschek B, Bettler B, et al. Distinct localization of GABA(B) receptors relative to synaptic sites in the rat cerebellum and ventrobasal thalamus. Eur J Neurosci 2002; 15: 291-307. (Pubitemid 35471951)
53. Laurie DJ, Seeburg PH, Wisden W. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J Neurosci 1992; 12: 1063-76.
54. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 2004; 13: 609-16. (Pubitemid 38379850)
55. Liang F, Hatanaka Y, Saito H, Yamamori T, Hashikawa T. Differential expression of gamma-aminobutyric acid type B receptor-1a and-1b mRNA variants in GABA and non-GABAergic neurons of the rat brain. J Comp Neurol 2000; 416: 475-95. (Pubitemid 30033488)
56. Linnemann C, Schmeh I, Thier P, Schwarz C. Transient change in GABA(A) receptor subunit mRNA expression in Lurcher cere-bellar nuclei during Purkinje cell degeneration. BMC Neurosci 2006; 7: 59.
57. Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM, et al. Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biol Psychiatry 2006; 60: 650-8. (Pubitemid 44402385)
58. Llinas RR. The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science 1988; 242: 1654-64. (Pubitemid 19022170)
59. Llinas R, Muhlethaler M. Electrophysiology of guinea-pig cerebellar nuclear cells in the in vitro brain stem-cerebellar preparation. J Physiol 1988; 404: 241-58.
60. Louis ED. Essential tremor. Lancet Neurol 2005; 4: 100-10. (Pubitemid 40138925)
61. Louis ED. A new twist for stopping the shakes? Revisiting GABAergic therapy for essential tremor. Arch Neurol 1999; 56: 807-8. (Pubitemid 29318905)
62. Louis ED. Essential tremors: a family of neurodegenerative disorders? Arch Neurol 2009; 66: 1202-8.
63. Louis ED, Faust PL, Vonsattel JP, Honig LS, Rajput A, Rajput A, et al. Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brains. Mov Disord 2009; 24: 1600-5.
64. Louis ED, Faust PL, Vonsattel JP, Honig LS, Rajput A, Robinson CA, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007; 130: 3297-307. (Pubitemid 350209079)
65. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010; 25: 534-41.
66. Louis ED, Rios E, Henchcliffe C. How are we doing with the treatment of essential tremor (ET)? Eur J Neurol 2010; 17: 882-4.
67. Louis ED, Vonsattel JP, Honig LS, Lawton A, Moskowitz C, Ford B, et al. Essential tremor associated with pathologic changes in the cerebellum. Arch Neurol 2006; 63: 1189-93. (Pubitemid 44232331)
68. Lozano AM, Dostrovsky J, Chen R, Ashby P. Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol 2002; 1: 225-31. (Pubitemid 37159184)
69. Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, et al. Benefits and risks of pharmacological treatments for essential tremor. Drug Saf 2003; 26: 461-81. (Pubitemid 36629784)
70. Mally J, Baranyi M. Change in the concentrations of amino acids in cisternal CSF of patients with essential tremor. J Neurol Neurosurg Psychiatry 1994; 57: 1012-3. (Pubitemid 24251081)
71. Mally J, Baranyi M, Vizi ES. Change in the concentrations of amino acids in CSF and serum of patients with essential tremor. J Neural Transm 1996; 103: 555-60. (Pubitemid 26383642)
72. Margeta-Mitrovic M, Mitrovic I, Riley RC, Jan LY, Basbaum AI. Immunohistochemical localization of GABA(B) receptors in the rat central nervous system. J Comp Neurol 1999; 405: 299-321. (Pubitemid 29104304)
73. Marshall FH, Foord SM. Heterodimerization of the GABAB receptor-implications for GPCR signaling and drug discovery. Adv Pharmacol 2010; 58: 63-91.
74. McAuley JH, Marsden CD. Physiological and pathological tremors and rhythmic central motor control. Brain 2000; 123: 1545-67. (Pubitemid 30481180)
75. Mexal S, Berger R, Adams CE, Ross RG, Freedman R, Leonard S. Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res 2006; 1106: 1-11. (Pubitemid 44163309)
76. Minen MT, Louis ED. Emergence of Parkinson's disease in essential tremor: a study of the clinical correlates in 53 patients. Mov Disord 2008; 23: 1602-5.
77. Miwa H. Rodent models of tremor. Cerebellum 2007; 6: 66-72. (Pubitemid 46410668)
78. Moghal S, Rajput AH, D'Arcy C, Rajput R. Prevalence of movement disorders in elderly community residents. Neuroepidemiology 1994; 13: 175-8. (Pubitemid 24197317)
79. Mouginot D, Gahwiler BH. Presynaptic GABAB receptors modulate IPSPs evoked in neurons of deep cerebellar nuclei in vitro. J Neurophysiol 1996; 75: 894-901.
80. Mutel V, Buchy D, Klingelschmidt A, Messer J, Bleuel Z, Kemp JA, et al. In vitro binding properties in rat brain of [3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B sub-units. J Neurochem 1998; 70: 2147-55. (Pubitemid 28207840)
81. Nicholson LFB, Faull RLM. GABAA receptor subunit subtypes in the human putamen and globus pallidus in Huntington disease. In: Ohye C, Kimura M, McKenzie J, editors. The Basal ganglia V. New York: Plenum Press; 1996.
82. Pahapill PA, Levy R, Dostrovsky JO, Davis KD, Rezai AR, Tasker RR, et al. Tremor arrest with thalamic microinjections of muscimol in patients with essential tremor. Ann Neurol 1999; 46: 249-52. (Pubitemid 29382882)
83. Pahwa R, Lyons KE, Wilkinson SB, Simpson RKJ, Ondo WG, Tarsy D, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg 2006; 104: 506-12.
84. Paterson NE, Malekiani SA, Foreman MM, Olivier B, Hanania T. Pharmacological characterization of harmaline-induced tremor activity in mice. Eur J Pharmacol 2009; 616: 73-80.
85. Petri S, Krampfl K, Dengler R, Bufler J, Weindl A, Arzberger T. Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra. J Comp Neurol 2002; 452: 360-6. (Pubitemid 35154498)
86. Pinault D, Deschenes M. The origin of rhythmic fast subthreshold depolarizations in thalamic relay cells of rats under urethane anaesthesia. Brain Res 1992; 595: 295-300.
87. Pinto AD, Lang AE, Chen R. The cerebellothalamocortical pathway in essential tremor. Neurology 2003; 60: 1985-7. (Pubitemid 36736019)
88. Rajput A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology 2004; 62: 932-6. (Pubitemid 38435781)
89. Rajput AH, Robinson CA, Rajput ML, Rajput A. Cerebellar Purkinje cell loss is not pathognomonic of essential tremor. Parkinsonism Relat Disord 2011; 17: 16-21.
90. Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 2009; 73: 206-12.
91. Rotter A, Rath S, Evans JE, Frostholm A. Modulation of GABA(A) receptor subunit mRNA levels in olivocerebellar neurons of purkinje cell degeneration and weaver mutant mice. J Neurochem 2000; 74: 2190-200. (Pubitemid 30217677)
92. Saller CF, Czupryna MJ. Gamma-Aminobutyric acid, glutamate, glycine and taurine analysis using reversed-phase high-performance liquid chromatography and ultraviolet detection of dansyl chloride derivatives. J Chromatogr 1989; 487: 167-72. (Pubitemid 19122061)
93. Schnitzler A, Munks C, Butz M, Timmermann L, Gross J. Synchronized brain network associated with essential tremor as revealed by magne-toencephalography. Mov Disord 2009; 24: 1629-35.
94. Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 2007; 13: 67-76. (Pubitemid 46329516)
95. Shill HA, Adler CH, Sabbagh MN, Connor DJ, Caviness JN, Hentz JG, et al. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 2008; 70: 1452-5. (Pubitemid 351521939)
96. Stani TM, Burchiel KJ, Hart MJ, Lenar DP, Anderson VC. Effects of DBS on precision grip abnormalities in essential tremor. Exp Brain Res 2009; 201: 331-8.
97. Tariq M, Arshaduddin M, Biary N, Al Moutaery K, Al Deeb S. Baclofen attenuates harmaline induced tremors in rats. Neurosci Lett 2001; 312: 79-82. (Pubitemid 32938233)
98. Tremblay C, Pilote M, Phivilay A, Emond V, Bennett DA, Calon F. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2007; 12: 377-90.
99. Turgeon SM, Albin RL. Pharmacology, distribution, cellular localization, and development of GABAB binding in rodent cerebellum. Neuroscience 1993; 55: 311-23. (Pubitemid 23211344)
100. Uusisaari M, Knopfel T. GABAergic synaptic communication in the GABAergic and non-GABAergic cells in the deep cerebellar nuclei. Neuroscience 2008; 156: 537-49.
101. Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S, et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006; 11: 615, 663-79. (Pubitemid 43989813)
102. Weis S, Llenos IC, Dulay JR, Elashoff M, Martinez-Murillo F, Miller CL. Quality control for microarray analysis of human brain samples: the impact of postmortem factors, RNA characteristics, and histopath-ology. J Neurosci Methods 2007; 165: 198-209. (Pubitemid 47212459)
103. Weiss N, North RB, Ohara S, Lenz FA. Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of gamma-aminobutyric acidergic pathways. Case report. J Neurosurg 2003; 99: 768-71. (Pubitemid 37159054)
104. Wisden W, Morris BJ. In situ hybridization protocols for the brain. San Diego: Academic Press; 1994.
105. Wong-Riley MT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989; 12: 94-101. (Pubitemid 19067056)
106. Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RBJ, et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005; 64: 2008-20. (Pubitemid 40880986)
107. Zesiewicz TA, Ward CL, Hauser RA, Pease Campbell JA, Sullivan KL. Pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord 2007; 22: 139-41. (Pubitemid 46382689)